Remove trial restrictions ▶ Start for $1

Serving leading biopharmaceutical companies globally:

AstraZeneca
Boehringer Ingelheim
McKesson
Moodys
Johnson and Johnson
Merck

Last Updated: August 17, 2022

MEN'S ROGAINE Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions


Which patents cover Men's Rogaine, and when can generic versions of Men's Rogaine launch?

Men's Rogaine is a drug marketed by Johnson And Johnson and is included in one NDA.

The generic ingredient in MEN'S ROGAINE is minoxidil. There are eight drug master file entries for this compound. Forty-seven suppliers are listed for this compound. Additional details are available on the minoxidil profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Men's Rogaine

A generic version of MEN'S ROGAINE was approved as minoxidil by WATSON LABS on March 3rd, 1987.

  Try it Free

Drug patent expirations by year for MEN'S ROGAINE
Recent Clinical Trials for MEN'S ROGAINE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Ohio State University Comprehensive Cancer CenterEarly Phase 1
Cures Within ReachPhase 2
Loyola UniversityPhase 2

See all MEN'S ROGAINE clinical trials

Pharmacology for MEN'S ROGAINE

US Patents and Regulatory Information for MEN'S ROGAINE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Johnson And Johnson MEN'S ROGAINE minoxidil AEROSOL, FOAM;TOPICAL 021812-001 Jan 20, 2006 OTC Yes Yes See Plans and Pricing See Plans and Pricing See Plans and Pricing
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

International Patents for MEN'S ROGAINE

See the table below for patents covering MEN'S ROGAINE around the world.

Country Patent Number Title Estimated Expiration
Japan 2007137899 MEDICINAL SOLUTION See Plans and Pricing
Canada 2328950 DERIVES DE PIPERIDINOPYRIMIDINE POUR APPLICATION TOPIQUE (PIPERIDINOPYRIMIDINE DERIVATIVES FOR TOPICAL APPLICATION) See Plans and Pricing
Portugal 1073439 See Plans and Pricing
Japan 3710380 See Plans and Pricing
Austria 331517 See Plans and Pricing
Australia 757601 See Plans and Pricing
Japan 2004059587 MEDICINAL COMPOSITION FOR HAIR TREATMENT See Plans and Pricing
>Country >Patent Number >Title >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Medtronic
McKinsey
Moodys
McKesson
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.